ETHOCUPS
Live / Applied — Third extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 29 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98204247
- Mark type
- Stylized text
- Filed
- 29 Sept 2023
- Published for opposition
- 23 Jul 2024
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of seizures and epilepsy; pharmaceutical products and substances for the treatment of central nervous system diseases; anti-convulsant
Owner
- Forte Bio-Pharma LLC, Las Vegas, NV, US
- Forte Bio-Pharma LLC, Las Vegas, NV, US
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 3 GRANTED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2025 — SOU EXTENSION 2 GRANTED
- 19 Aug 2025 — SOU EXTENSION 2 FILED
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2025 — SOU EXTENSION 1 GRANTED
- 20 Feb 2025 — SOU EXTENSION 1 FILED
- 20 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jul 2024 — PUBLISHED FOR OPPOSITION
- 03 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED